Table 2.
Limitations of pharmacologic therapy for chronic pain
Therapeutic class | Major limitations |
---|---|
Nonselective NSAIDs | Risk for gastrointestinal toxicitya |
Recommended use of concomitant gastroprotective agents | |
increases costa | |
Risk for renal toxicitya | |
Cardiovascular safety issuesb | |
COX-2 Inhibitors | Increased risk |
Cardiovascular safety issuesc | |
Renal toxicitya | |
Opioids | Associated with: Reduced cognitive and motor functiond |
Respiratory depressione | |
Fear of dependence/tolerance/abusef | |
Stringent regulatory requirements and potential for scrutiny maylimit adequate prescribingf |
Notes: ACR 2000
Abbreviations: COX-2, cyclooxygenase-2; NSAIDs, nonsteroidal antiinflammatory drugs.